NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NINDS E-008-2009-0-US-01 ACXCL13 And Endothelin 2 Promote Myelination By Adult CNS Precursor
cell 		US 61/153,860 Abandoned
NIA E-059-2006-0-US-07 Method Of Treating Or Preventing Oxidative Stress-Related Disease US National Stage 12/377,881 Abandoned
NCI E-198-2006-0-US-03 Anti-H5N1 Influenza Activity Of The Antiviral Protein Cyanovirin-N (CV-N) US National Stage 12/377,875 Abandoned
NIAID E-086-2009-0-US-01 Synthetic HIV/SIV GAG Proteins and Uses Thereof US 61/153,622 Abandoned
NCI E-198-2006-0-EP-04 Anti-H5N1 Influenza Activity Of The Antiviral Protein Cyanovirin-N (CV-N) EP National Stage 07814209.8 Abandoned
NICHD E-032-2008-0-PCT-02 Use Of Saccharides Cross-reactive With Bacillus Anthracis Spore Glycoprotein As A Vaccine Against Anthrax. PCT PCT PCT/US2009/000995 Expired
NCI E-340-2008-0-US-01 Stratification Of Breast Cancer Patients Based On Chromosome 8p 11-12 Amplification Anti/or EIP4EBP1 Over-expression For Therapeutic Interventions With Rapamycin And Its Analogs Against Local Advanced And Metastatic Breast Cancer US 61/152,920 Abandoned
NCI E-007-2004-0-US-07 Pyrrolobenzodiazepine Derivatives, Compositions, Comprimising The Same And Methods Related Thereto US CON 12/370,856 7834005 Abandoned PDF
CC E-254-2007-0-US-02 Encapsulated Nanoparticles For Computed Tomography Imaging US ORD 12/371,472 Abandoned
NCI E-023-2009-0-US-01 A Molecular-Based Methods of Cancer Diagnosis and Prognosis US 61/152,597 Abandoned
NINDS E-143-2007-0-US-03 Octanoic Acid Formulations And Methods Of Treatment Using The Same US National Stage 12/867,702 Abandoned
NINDS E-143-2007-0-EP-04 OCTANOIC ACID FORMULATIONS AND METHODS OF TREATMENT USING THE SAME EP National Stage 09710855.9 Abandoned
NIDCR E-063-2009-0-US-01 Serological Screening For HHV-8 Infection Using Antigen Mixtures US 61/152,058 Abandoned
NIAID E-124-2009-0-US-01 Influenza Hemagglutinin And Neuraminidase Variants US 61/152,094 Abandoned
NINDS E-143-2007-0-PCT-02 Use Of Carboxylic Acid Derivatives Of Octanol To Treat Alcohol Responsive Disorders Including Essential Tremor And Myoclonus PCT PCT PCT/US09/000876 Expired
NCI E-016-2008-0-PCT-02 Modified SugarSubstrates and Methods of Use PCT PCT PCT/US2009/33842 Abandoned
NCI E-003-2008-0-AU-05 Methods Of Obtaining Antigen-Specific T Cell Populations AU National Stage 2009214980 Abandoned
NCI E-017-2008-0-EP-05 Compounds With MDR1-Inverse Activity EP National Stage 09711250.2 Abandoned
NCI E-017-2008-0-DE-07 Compounds With MDR1-Inverse Activity DE EP 09711250.2 Abandoned
NCI E-017-2008-0-FR-08 Compounds With MDR1-Inverse Activity FR EP 09711250.2 Abandoned
NCI E-017-2008-0-GB-09 Compounds With MDR1-Inverse Activity GB EP 09711250.2 Abandoned
NCI E-017-2008-0-PCT-02 A Pharmacophore For Isatin-beta-thiosemicarbazone Compounds With MDR1-Inverse Activity PCT PCT PCT/US2009/000861 Expired
NCI E-003-2008-0-PCT-02 A Novel High Throughput Technique To Isolate Rare Autologous Antigen Specific Human T-cells From Peripheral Blool Repertoire For Cancer Therapy PCT PCT PCT/US2009/33649 Expired
NICHD E-304-2005-0-US-03 Methods for Treatment and Diagnosis of Psychiatric Disorders US National Stage 12/377,025 Abandoned
NCI E-003-2008-0-EP-03 Methods of Obtaining Antigen-Specific T Cell Populations EP National Stage 09710958.1 Abandoned
NCI E-017-2008-0-AU-03 Compounds With MDR1-Inverse Activity AU National Stage 2009213153 Abandoned
CC E-298-2008-0-US-01 MRI Coil For Dynamic And Static Knee And Ankle Imaging US 61/151,300 Abandoned
NCI E-017-2008-0-CA-04 A Pharmacophore For Isatin-beta-thiosemicarbazone Compounds With MDR1-Inverse Activity CA National Stage 2713288 Abandoned
NIA E-205-2006-2-US-13 Preparation Of R,R-fenoterol And R,R-fenoterol Analogues And Their Use In Congestive Heart Failure US National Stage 12/376,945 Abandoned
NIDCD E-084-2009-0-US-01 Diagnostic And Therapeutic Uses Of GNPTAB, GNPTG, And NAGPA In Stuttering US 61/150,954 Abandoned
NIAID E-139-2006-0-US-09 Development of Dengue Virus Vaccine Components US National Stage 12/376,756 8337860 Issued PDF
NIAID E-102-2008-2-PCT-01 MODIFICATION OF ANTIGENS WHILE MAINTAINING ANTIBODY BINDING EPITOPES PCT PCT COMB PCT/US2009/033457 Expired
NIAID E-019-2007-2-JP-08 Vaccines Against Potential Pandemic Strains Of Influenza JP National Stage 2009523998 Abandoned
NIAID E-019-2007-2-CN-05 Influenza Hemagglutinin and Neuraminidase Variants CN National Stage 200780029510.X Abandoned
NIAID E-304-2004-0-US-05 Sequence Analysis Of The Tetravalent Rotavirus Vaccine US DIV 12/365,122 Abandoned
NCI E-040-2004-0-US-03 Methods for the Production of Biliverdin US DIV 12/364,054 Abandoned
NCI E-003-2007-0-CA-04 Engineered Antibody Constant Domain Molecules CA National Stage 2713281 Issued
NCI E-003-2007-0-IN-09 Engineered Antibody Constant Domain Molecules IN National Stage 2818/KOLNP/2010 Issued
NCI E-003-2007-0-JP-07 Engineered Antibody Constant Domain Molecules JP National Stage 2010-545219 Issued
NCI E-003-2007-0-EP-10 Engineered Antibody Constant Domain Molecules EP DIV 12198382.9 Issued
NCI E-003-2007-0-GB-22 Engineered Antibody Constant Domain Molecules GB EP 12198382.9 Issued
NCI E-003-2007-0-CH-19 Engineered Antibody Constant Domain Molecules CH EP 12198382.9 Issued
NCI E-003-2007-0-FR-21 Engineered Antibody Constant Domain Molecules FR EP 12198382.9 Issued
NCI E-003-2007-0-DE-20 Engineered Antibody Constant Domain Molecules DE EP 12198382.9 Issued
NCI E-003-2007-0-CN-05 Engineered Antibody Constant Domain Molecules CN National Stage 200980110221.1 Issued
NCI E-003-2007-0-AU-03 Engineered Antibody Constant Domain Molecules AU National Stage 2009212747 Issued
NCI E-003-2007-0-GB-14 Engineered Constant Domain Molecule of an Antibody GB EP 09709399.1 Issued
NCI E-003-2007-0-CH-11 Engineered Constant Domain Molecule of an Antibody CH EP 09709399.1 Issued
NCI E-003-2007-0-DE-12 Engineered Constant Domain Molecule of an Antibody DE EP 09709399.1 Issued
NCI E-003-2007-0-FR-13 Engineered Constant Domain Molecule of an Antibody FR EP 09709399.1 Issued